The impact of pneumococcal disease on adults living in Bogota, Colombia, 2008;Impacto de la enfermedad por streptococcus pneumoniae en población adulta mayor en Bogotá, Colombia, 2008

Revista de Salud Publica

Volumn 12, Issue 1, 2010, Pages 38-50

  Castañeda Orjuela, Carlos ^a   Alvis Guzmán, Nelson ^b   de la Hoz Restrepo, Fernando ^a  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b UNIVERSIDAD DE CARTAGENA   (Colombia)

Author keywords

Epidemiology; Meningitis; Pneumonia; Streptococcus pneumoniae

Indexed keywords

AGED; AMBULATORY CARE; COLOMBIA; HOSPITALIZATION; HUMAN; INCIDENCE; MENINGITIS, PNEUMOCOCCAL; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMONIA, PNEUMOCOCCAL; STATISTICS AND NUMERICAL DATA; URBAN POPULATION;

AGED; COLOMBIA; HOSPITALIZATION; HUMANS; INCIDENCE; MENINGITIS, PNEUMOCOCCAL; MIDDLE AGED; OFFICE VISITS; PNEUMOCOCCAL INFECTIONS; PNEUMONIA, PNEUMOCOCCAL; URBAN POPULATION;

EID: 77958023378     PISSN: 01240064     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0124-00642010000100004     Document Type: Article

References (45)

1. WHO. The World health report 2005: make every mother and child count [Internet]. Geneva: World Health Organization; 2009. Disponible en: http://www.who.int/whr/2005/whr2005_en.pdf Consultado: junio de 2009.
2. Burman LA, Norrby R, Trollfors B. Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. Rev Infect Dis. 1985 Mar-Apr;7(2):133-42.
3. Ortqvist A, Hedlund J, Kalin M. Streptococcus pneumoniae: epidemiology, risk factors, and clinical features. Semin Respir Crit Care Med. 2005 Dec;26(6):563-74.
4. Monto AS. Acute respiratory infection in children of developing countries: challenge of the 1990s. Rev Infect Dis. 1989 May-Jun;11(3):498-505.
5. Pneumococcal vaccines. WHO position paper. Wkly Epidemiol Rec. 1999 Jun 11;74(23):177-83.
6. Fedson DS, Scott JA. The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known. Vaccine. 1999 Jul 30;17 Suppl 1:S11-8.
7. De la Hoz F, Álvis N, Narváez J, Orozco J, L. A. Evaluación del impacto epidemiológico y económico de la introducción de la vacuna del neumococo en Colombia. Infectio. 2008;12(S1):90.
8. Cortes M, Pereira J, Pena-Rey I, Genova R, Amela C. Disease burden due to vaccinable diseases in the Spanish population aged less than 15 years old. Gac Sanit. 2004 Jul- Aug;18(4):312-20.
9. Maurice J. First countries to be recipients of GAVI funds. Bull World Health Organ. 2000;78(12):1477-8.
10. Wittet S. Introducing GAVI and the Global Fund for Children's Vaccines. Vaccine. 2000 Oct 15;19(4-5):385-6.
11. Balaji KA. GAVI and the Vaccine Fund-a boon for immunization in the developing world. Indian J Public Health. 2004 Apr-Jun;48(2):45-8.
12. Kaddar M, Lydon P, Levine R. Financial challenges of immunization: a look at GAVI. Bull World Health Organ. 2004 Sep;82(9):697-702.
13. Kumar A, Puliyel J. GAVI funding and assessment of vaccine cost-effectiveness. Lancet. 2007 Jan 20;369(9557):189.
14. The GAVI Alliance's new vaccine strategy. Lancet. 2008 Jul 5;372(9632):2.
15. Goldie SJ, O'Shea M, Campos NG, Diaz M, Sweet S, Kim SY. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries. Vaccine. 2008 Jul 29;26(32):4080-93.
16. Lydon P, Levine R, Makinen M, Brenzel L, Mitchell V, Milstien JB, et al. Introducing new vaccines in the poorest countries: What did we learn from the GAVI experience with financial sustainability? Vaccine. 2008 Oct 24;26(51);6706-16.
17. Lob-Levyt J. Vaccine coverage and the GAVI Alliance Immunization Services Support initiative. Lancet. 2009 Jan 17;373(9659):209.
18. Naimoli JF. Global health partnerships in practice: taking stock of the GAVI Alliance's new investment in health systems strengthening. Int J Health Plann Manage. 2009 Jan 22;14:3-25.
19. Drummond M, O'Brien B, Stoddart G, Torrance G. Methods for the economic evaluation of health care programs. Second Edition ed. Oxford GB: Oxford Medical Publications; 1997.
20. Díaz A, Barria P, Niederman, Restrepo M I, Dreyse J, Fuentes G, et al. Etiology of Community- Acquires Pneumonia in Hospitalized Patients in Chile. Chest 2007; 131:779-87.
21. Diaz A, Calvo M, O'Brien A, Farias G, Mardonez JM, Saldias F. [Clinical usefulness of blood cultures in hospitalized patients with community-acquired pneumonia]. Rev Med Chil. 2002 Sep;130(9):993-1000.
22. Matute AJ, Brouwer WP, Hak E, Delgado E, Alonso E, Hoepelman IM. Aetiology and resistance patterns of community-acquired pneumonia in Leon, Nicaragua. Int J Antimicrob Agents. 2006 Nov;28(5):423-7.
23. Riquelme OR, Riquelme OM, Rioseco ZM, Gomez MV, Gil DR, Torres MA. [Etiology and prognostics factors of community-acquired pneumonia among adults patients admitted to a regional hospital in Chile]. Rev Med Chil. 2006 May;134(5):597-605.
24. Saldias F, Mardonez JM, Marchesse M, Viviani P, Farias G, Diaz A. Community-acquired pneumonia in hospitalized adult patients. Clinical presentation and prognostic factors. Rev Med Chil. 2002 Dec;130(12):1373-82.
25. Szot Meza J. Mortalidad por enfermedades respiratorias en Chile durante 1999. Rev chil enferm respir. 2003;19(1):8-14.
26. Dintrans K, Andrade C, Sánchez J, Mendoza J. Neumonía adquirida en la comunidad en adultos, en el curso de la campaña de invierno 2003 en el Hospital San Juan de Dios / Community acquired pneumonia in adults during winter 2003 campaign at a Santiago general hospital Rev chil enferm respir. 2005; 21(1):15-22.
27. de Oliveira Rossoni AM, Dalla Costa LM, Berto DB, Farah SS, Gelain M, de Cunto Brandileone MC, et al. Acute bacterial meningitis caused by Streptococcus pneumoniae resistant to the antimicrobian agents and their serotypes. Arq Neuropsiquiatr. 2008 Sep;66(3A):509-15.
28. Dickinson FO, Pérez A E. Meningoencefalitis bacterianas en Cuba Rev Cubana Hig Epidemiol. 2001;39(2):86-94.
29. Dickinson FO, Perez AE. Bacterial meningitis in children and adolescents: an observational study based on the national surveillance system. BMC Infect Dis. 2005 Nov 15;5:103.
30. Dickinson-Meneses F, Pérez-Rodríguez A. Meningoencefalitis bacterianas en el adulto mayor cubano 1998-2000. Geriátrika 2002;18(6):32-40.
31. Gomes I, Lucena R, Melo A. [Clinical and laboratory characteristics of pyogenic meningitis in adults]. Arq Neuropsiquiatr. 1997 Sep;55(3B):584-7.
32. Inostroza J, Vinet AM, Retamal G, Lorca P, Ossa G, Facklam RR, et al. Influence of patient age on Streptococcus pneumoniae serotypes causing invasive disease. Clinical and Diagnostic Laboratory Immunology. 2001 May;8(3):556-9.
33. Levin AS, Sessegolo JF, Teixeira LM, Barone AA. Factors associated with penicillinnonsusceptible pneumococcal infections in Brazil. Brazilian Journal of Medical and Biological Research. [Article]. 2003 June;36(6):807-13.
34. Maldonado A, Seoane M, San Martin O, Hormazabal JC, Lagos R. Retrospective assessment of laboratory surveillance for invasive Streptococcus pneumoniae isolates from adults of the Metropolitan Region (Chile): 2000-2006. Rev Chilena Infectol. 2007 Dec;24(6):446-52.
35. Diaz A, Torres C, Flores LJ, Garcia P, Saldias F. Community acquired pneumococcal pneumonia in hospitalized adult patients. Rev Med Chil. 2003 May;131(5):505-14.
36. Gentile JH, Sparo MD, Mercapide ME, Luna CM. Adult bacteremic pneumococcal pneumonia acquired in the community. A prospective study on 101 patients. Medicina (Buenos Aires). 2003;63(1):9-14.
37. Noriega LM, Gonzalez P, Canals C, Michaud P. Streptococcus pneumoniae septicemia. Analysis of 40 cases. Rev Med Chil. 1994 Dec;122(12):1385-92.
38. Iraola Ferro M, Estevan Collazo M, Bueno Pérez S, Calegari Costa A, Lapides Kancer M, Souto G, et al. La neumonía del niño hospitalizado de cinco a catorce años de edad Arch pediatr Urug. 2005;76(3):196-201.
39. Diaz A, Alvarez M, Callejas C, Rosso R, Schnettler K, Saldias F. Clinical picture and prognostic factors for severe community-acquired pneumonia in adults admitted to the intensive care unit. Arch Bronconeumol. 2005 Jan;41(1):20-6.
40. Diaz A, Vera C, Santamarina J, Izarduy L, Bagnesco R, Grinspon S et al. Neumonía adquirida en la comunidad en acncianos que requieren internación. Cuadro clínico y pronóstico. Medicina (Arg) 1999; 59(6):731-8.
41. Ojeda G. Salud Sexual y Reproductiva en Colombia [Internet]. Encuesta Nacional de Demografía y Salud 2005. Cap XIV: 443-81. Bogotá D.C.: PROFAMILIA; 2006; Disponible en: http://www.profamilia.org.co/encuestas/01encuestas/pdf_2005/capitulo_XIV.pdf. Consultado: junio de 2009.
42. Ortqvist A, Hedlund J, Burman LA, Elbel E, Hofer M, Leinonen M, et al. Randomised trial of 23- valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group. Lancet. 1998 Feb 7;351(9100):399-403.
43. Jackson ML, Neuzil KM, Thompson WW, Shay DK, Yu O, Hanson CA, et al. The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis. 2004 Dec 1;39(11):1642-50.
44. CDC. Prevention of neumococcal diseases. Recommendations of the Advisory Committee on Immunisation Practices. MMWR 1997; 46 (RR-8):1-24.
45. Bogaert D, Hermans P, Adrian P, Rumke H, De Groot R. Pneumococcal vaccines: An update on current strategies. Vaccine 2004; 22:2209-2220.